The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations (UM1 Clinical Trial Required)
National Institutes of Health
This opportunity closed June 30, 2026. 5 similar opportunities are open right now.
Similar opportunities open now
- The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Nov 2028Up to $500K
- Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)OpenNational Institutes of HealthCloses Oct 2027Up to $300K
- Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)OpenNational Institutes of HealthCloses in 81 daysUp to $600K
- Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Jul 2029
- Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)OpenNational Institutes of HealthCloses in 81 daysUp to $600K
About this archived opportunity
The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations (UM1 Clinical Trial Required) - Federal funding opportunity from National Institutes of Health. Full description and eligibility details will be available after enrichment completes. Visit the Grants.gov detail page for complete information.
Historical details
- Status
- Closed
- Deadline
- June 30, 2026
- First captured
- October 23, 2025
- Award
- $11,800,000
- Publisher reference
- 359133
Eligibility: Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Eligible institution/organization for the purposes of this application is defined as an academic center/organization in the United States or Canada providing direct medical care to patients that is considered one integral organizational entity under a single financial management system and governance structure. A center/organization (e.g., an academic hospital and/or academic clinic program) for this application is distinguished from large medical centers whose primary mission is patient care. In addition to patient care, academic centers/organizations have comprehensive medical training programs, investigational pharmacies, advanced imaging facilities, and preclinical laboratories that perform basic research.The only Non-domestic (non-U.S.) Entities (Foreign Institutions) allowed in response to this NOFO are Canadian Institutions.Foreign Organizations/Foreign Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
This opportunity has closed
The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations (UM1 Clinical Trial Required)
by National Institutes of Health
Get notified when similar opportunities open
We'll save this search and email you when new experimental, therapeutics, clinical opportunities are posted. Free.
Related opportunities
- The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)National Institutes of HealthCloses Nov 2028Up to $500K
- Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)National Institutes of HealthCloses Oct 2027Up to $300K
- Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)National Institutes of HealthCloses in 81 daysUp to $600K
- Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)National Institutes of HealthCloses Jul 2029